When the body suffers from infection, trauma, or other diseases, the immune system releases inflammatory mediators, such as IL and TNF, which can affect the composition and function of gut microbiota, even leading to increased gut permeability, allowing the gut microbiota and its metabolites to enter the bloodstream, further inducing systemic inflammatory reactions (Ji et al., 2023)
sourcing a tested material, however, does not change the evidence picture described above trial data still do not transfer to any specific product, CagriSema remains investigational, and nothing here is a therapeutic recommendation or a protocol for use
These emerging clinical trials strongly suggest that the mitochondrial support provided by carnitine is not just theoretical
The fact that the tested peptides increased ROS production and disrupted mitochondrial functionality was confirmed by the detection of increased cytosolic Ca 2+ concentration after peptide treatment of C